Company
Headquarters: Lynnwood, WA, United States
CEO: Nickoloaus D. Skouras
Company | Market Cap (USD) |
---|---|
Zoetis Inc. | $89.09 B |
MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
Takeda Pharmaceutical Company Limited | $47.71 B |
Haleon plc | $38.90 B |
PPD, Inc. | $16.58 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Coenzyme-A Inc. formulates and manufactures nutraceutical supplements, and skin and hair care products in the United States and internationally. It offers energy drinks and skin rejuvinating serums, as well as fat management, skin treatment, fatty acid and cholesterol metabolism, and skin rejuvenating products, as well as nutritional formulas for the support of bone, joint, ligament, cartilage, and connective tissue functions. The company also provides sports-specific, women's, and men's formulas, as well as wellness, energy, and body sculpting products. Coenzyme-A Inc. was founded in 1998 and is based in Lynnwood, Washington.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Coenzyme A, Inc. has the following listings and related stock indices.
Stock: OTC: PPII wb_incandescent
Headquarters:
12512 Beverly Park Road
B1
Lynnwood, WA 98087
United States
Phone: 425-438-8586
Fax: 425-438-8766